Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.

PubWeight™: 4.48‹?› | Rank: Top 1%

🔗 View Article (PMID 29694816)

Published in N Engl J Med on April 26, 2018

Authors

Jeremy D Keenan1, Robin L Bailey1, Sheila K West1, Ahmed M Arzika1, John Hart1, Jerusha Weaver1, Khumbo Kalua1, Zakayo Mrango1, Kathryn J Ray1, Catherine Cook1, Elodie Lebas1, Kieran S O'Brien1, Paul M Emerson1, Travis C Porco1, Thomas M Lietman1, MORDOR Study Group

Author Affiliations

1: From the Francis I. Proctor Foundation (J.D.K., K.J.R., C.C., E.L., K.S.O., T.C.P., T.M.L.), the Departments of Ophthalmology (J.D.K., T.C.P., T.M.L.) and Epidemiology and Biostatistics (T.C.P., T.M.L.), and the Institute for Global Health Sciences (T.C.P., T.M.L.), University of California, San Francisco, San Francisco; London School of Hygiene and Tropical Medicine, London (R.L.B., J.H.); the Dana Center, Johns Hopkins University School of Medicine, Baltimore (S.K.W., J.W.); the Carter Center, Niamey, Niger (A.M.A.); Blantyre Institute for Community Outreach and the College of Medicine, University of Malawi, Blantyre (K.K.); National Institute for Medical Research, Dar es Salaam, Tanzania (Z.M.); and the International Trachoma Initiative, Decatur (P.M.E.), and Emory University, Atlanta (P.M.E.) - both in Georgia.

Associated clinical trials:

Mortality Reduction After Oral Azithromycin: Mortality Study (MORDOR) | NCT02047981

Azithromycin for Child Survival in Niger: Implementation and Research (AVENIR) (AVENIR) | NCT04224987

Articles by these authors

Azithromycin and Childhood Mortality in Africa. N Engl J Med (2018) 0.75